🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

More research is desperately needed to improve treatments for ocular melanoma patients. Your tax-deductible donation will directly support clinical research to improve the success of immunotherapy and help patients retain their vision. 🙏 masc.org.au/donate-to-ocul… ONCODOC

👁️ This Saturday! Register now for the AOMA Virtual Summit. 14 experts + 4 consumers will deliver talks. Anyone interested in ocular melanoma should attend. It's free! masc.org.au/aoma-summit/

10 days after Michelle Taylor was diagnosed with ocular melanoma, her affected eye was removed. New ocular melanoma therapies are urgently needed so that patients like Michelle don’t have to go through life altering surgery. Donate to OM research: masc.org.au/donate-to-ocul…

In the 8 years since my eye was removed, the ocular melanoma landscape is changing, but not enough to guarantee my survival should it ever metastasise. Please consider donating to fund research into this rare disease to improve outcomes. Australasian Ocular Melanoma Alliance (AOMA) Melanoma and Skin Cancer Trials (MASC Trials) Rare Cancers Australia

A great start to the 2024 AOMA Virtual Summit, with US speakers Dr Richard Carvajal covering international clinical trials and Melody Burchett from A Cure In Sight on advocacy and mental health for patients. Joined by meeting convenor, Dr Tim Isaacs.

ONCODOC Australasian Ocular Melanoma Alliance (AOMA) Melanoma and Skin Cancer Trials (MASC Trials) Shackleton Laboratory Matteo Carlino CURE Ocular Melanoma Melanoma Institute Australia Great to hear from patient advocates like Melody Burchett A Cure In Sight highlighting importance of patient advocacy, clinical trials and unmet emotional needs of UM pts. Will be sharing learnings on #fearofrecurrence and how pts/drs can better support this unmet need. POCOG

Interesting activity and tolerability of antibody drug conjugates targeting GNAQ/11 with non-cytotoxic payload in uveal melanoma presented by Matteo Carlino at #AOMA24 Summit Australasian Ocular Melanoma Alliance (AOMA) Melanoma and Skin Cancer Trials (MASC Trials)

2024 AOMA Summit continues with A/Prof Matt Carlino from Melanoma Institute Australia talking about targeting GNAQ and GNA11 in uveal melanoma, and Anne Goulter from NZ who travels to Australia each week for a Tebentafusp infusion. ONCODOC Melanoma and Skin Cancer Trials (MASC Trials)

If you missed Illana Klevansky's talk about her ocular melanoma journey at today's AOMA Summit, you can read it here: masc.org.au/illana/ Melanoma and Skin Cancer Trials (MASC Trials)

👁️ Videos of the 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit, Sat 15 June, are now available online. Watch all the sessions or only the videos you are interested in. masc.org.au/aoma-summit/ A Cure In Sight Ocular Melanoma UK CURE Ocular Melanoma Melanoma Australia Melanoma Institute Australia

🚨 Time is running out to make a difference for ocular melanoma patients. Thanks to advocates like Susan Vine, support and awareness of this rare cancer is growing. But funding is urgently needed to improve outcomes for ocular melanoma patients. Donate: masc.org.au/donate-to-ocul…

Anne Gately is a stage IV melanoma survivor, author of Sunburnt & wants to change the ‘bronzed Aussie’ culture. Hear her talk on ‘How Australia’s culture primed us for skin cancer’ at the 2024 MASC Trials ASM, 24 Oct 2024, Sydney. Register: masc.org.au/asm-2024/ Melanoma Institute Australia

The Melanoma and Skin Cancer Trials (MASC Trials) 2024 Annual Scientific Meeting has a session dedicated to ocular melanoma clinical trials, research advances, and consumer perspectives. Register today👇

BETTER trial is investigating new treatment combo using immunotherapy drugs & targeted radiotherapy for patients with melanoma brain metastases. Thanks to a generous donation from AustralianSkinCancerFoundation Foundation, this trial is in start-up phase. masc.org.au/better/ Malaka Ameratunga

Dr Wen Xu, senior lecturer at University of Queensland is presenting ‘Immunotherapy Merkel Adjuvant Trial (I-MAT) and Australasian Merkel Cell Carcinoma Interest Group (AMIGOs)’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

Ana Ratapu, stage IV melanoma survivor with a clinical nursing background caring for melanoma and breast cancer patients, is presenting ‘An international journey to access a clinical trial’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/

Angela Cairns, Manager at #TransplantAustralia, and mum, wife, and daughter-in-law of heart recipients is presenting ‘Transplant recipients and skin cancer: The lived experience’ at the 2024 MASC Trials ASM, 24 Oct in Sydney. Seats are limited! Register: masc.org.au/asm-2024/

Prof Anthony Joshua presenting at MASC Trials ASM (24 October 2024) and our Consumer Advisory Panel Deputy Chair, Michelle Taylor sharing her story - Two eyes aren't always better than one! #ASM2024 #OcularMelanoma #ClinicalTrials #ProfAnthonyJoshua

Thank you to Dr Louise Nott, Profs Anthony Joshua and Mark Shackleton, and Tasmanian attendees for joining the MASC Trials team at the AOMA Hobart meeting at Crowne Plaza Hobart on Friday evening. Many thanks to Medison for sponsoring this event! #MASCTrials #Medison

We are excited to announce that the Australasian Ocular Melanoma Alliance Virtual Summit will be returning in 2025! Keep an eye on our socials for further details 👁️